Baseline characteristics of the patients with rheumatoid arthritis (n = 102)
| Demography | |
|---|---|
| Age (years), mean (SD) | 53 (13) |
| Sex, female, n (%) | 84 (82) |
| Disease duration years, median (range) | 8 (1–49) |
| Erosive disease, n (%) | 84 (82) |
| IgM-RF positive, n (%) | 75 (74) |
| Disease activity | |
|---|---|
| DAS-28, mean (SD) | 5.4 (1.2) |
| ESR (mm/h), mean (SD) | 32 (23) |
| CRP (mg/l), median (range) | 14 (1–174) |
| Drugs | |
|---|---|
| Methotrexate, n (%) | 98 (96) |
| Prednisone, n (%) | 46 (45) |
| Anti-osteoporotic drugs, n (%) | 26 (26) |
| BMD | |
|---|---|
| BMD, bone mineral; CRP, C reactive protein, DAS-28, Disease Activity Score of 28 joints; ESR, erythrocyte sedimentation rate; IgM-RF, immunoglobulin G-rheumatoid factor. | |
| Vertebral spine (g/cm2), mean (SD), n = 102 | 0.993 (0.19) |
| t Score, mean (SD) | −0.82 (1.6) |
| z Score, mean (SD) | −0.09 (1.5) |
| Total hip (g/cm2), mean (SD), n = 89 | 0.830 (0.14) |
| t Score, mean (SD) | −1.02 (1.2) |
| z Score, mean (SD) | −0.51 (1.2) |
| Hand, mean (SD), n = 53 | 0.497 (0.98) |